AIM movers: Thalia Therapeutics acquisition and Velocity Composites second half hit by business mix
Thalia Therapeutics (LON: THAT), formerly N4 Pharma, is acquiring Sanmirna Therapeutics Inc, which is developing miRisten for the treatment of…
0,008€
7,14%
Echtzeit-Aktienkurs N4 PHARMA PLC -,004
Bid:
Ask:
Nachrichten zur N4 PHARMA PLC -,004 Aktie
AIM movers: WH Ireland selling wealth management business and Nuvec success for N4 Pharma
N4 Pharma (LON: N4P) along with its partner SRI has achieved precision targeting of the Nuvec gene delivery system. A…
N4 Pharma shares rise on lung cancer cell targeting update
N4 Pharma shares rose on Monday after announcing an update on its collaborations with the research institute SRI to test…
Form 8.5 (EPT/RI)-Alliance Pharma plc
FORM 8.5 (EPT/RI) …
Form 8.5 (EPT/RI)-Alliance Pharma plc
swswFORM 8.5 (EPT/RI) …
Form 8.5 (EPT/RI)-Alliance Pharma plc
FORM 8.5 (EPT/RI) …
Form 8.5 (EPT/RI)-Alliance Pharma plc
FORM 8.5 (EPT/RI) …
AIM movers: Mkango Resources intends to spin off assets in Nasdaq shell and RBG terminates Ian Rosenblatt consultancy
Former Avacta boss Dr Alastair Smith has become a non-executive director of gene delivery technology developer N4 Pharma (LON: N4P).…